Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status-Reference-Cited by-同舟云学术

Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status

Published:2021-10 Issue:10 Volume:27 Page:1516.e7-1516.e14
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Eyre David W.,Lumley Sheila F.,Wei Jia,Cox Stuart,James Tim,Justice Anita,Jesuthasan Gerald,O'Donnell Denise,Howarth Alison,Hatch Stephanie B.,Marsden Brian D.,Jones E. Yvonne,Stuart David I.,Ebner Daniel,Hoosdally Sarah,Crook Derrick W.,Peto Tim E.A.,Walker Timothy M.,Stoesser Nicole E.,Matthews Philippa C.,Pouwels Koen B.,Walker A. Sarah,Jeffery Katie

Funder

National Institute for Health Research

United Kingdom Department of Health and Social Care

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference18 articles.

1. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial;Folegatti;Lancet,2020

2. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months;Wajnberg;Science,2020

3. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment;GeurtsvanKessel;Nat Commun,2020

4. MHRA guidance on coronavirus (COVID-19);Medicines and Healthcare products Regulatory Agency,2020

5. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates;Walsh;N Engl J Med,2020

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-step synthesized multisize AuAg alloy nanoparticles with high SERS sensitivity in directly detecting SARS-CoV-2 spike protein;Analytica Chimica Acta;2024-08

2. Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles;PLOS ONE;2024-07-29

3. Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data;Vaccines;2024-06-20

4. Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination;BMC Infectious Diseases;2024-04-24

5. Association of Prior COVID-19 Infection with Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran;International Journal of Preventive Medicine;2024-04